|
1
|
Mayeux R and Stern Y: Epidemiology of
Alzheimer disease. Cold Spring Harb Perspect Med.
2:a0062392012.PubMed/NCBI
|
|
2
|
Yao M, Nguyen TV and Pike CJ:
Beta-amyloid-induced neuronal apoptosis involves c-Jun N-terminal
kinase-dependent downregulation of Bcl-w. J Neurosci. 25:1149–1158.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hardy JA and Higgins GA: Alzheimer's
disease: The amyloid cascade hypothesis. Science. 256:184–185.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tayeb HO, Murray ED, Price BH and Tarazi
FI: Bapineuzumab and solanezumab for Alzheimer's disease: Is the
‘amyloid cascade hypothesis’ still alive? Expert Opin Biol Ther.
13:1075–1084. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Doody RS, Thomas RG, Farlow M, Iwatsubo T,
Vellas B, Joffe S, Kieburtz K, Raman R, Sun X, Aisen PS, et al:
Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's
disease. N Engl J Med. 370:311–321. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Salloway S, Sperling R, Fox NC, Blennow K,
Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S,
et al: Two phase 3 trials of bapineuzumab in mild-to-moderate
Alzheimer's disease. N Engl J Med. 370:322–333. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Karran E and Hardy J: Antiamyloid therapy
for Alzheimer's dis-ease-are we on the right road? N Engl J Med.
370:377–378. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Golde TE, Schneider LS and Koo EH: Anti-aβ
therapeutics in Alzheimer's disease: The need for a paradigm shift.
Neuron. 69:203–213. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kaminsky YG, Marlatt MW, Smith MA and
Kosenko EA: Subcellular and metabolic examination of amyloid-beta
peptides in Alzheimer disease pathogenesis: Evidence for Abeta
(25–35). Exp Neurol. 221:26–37. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yuan H, Zhang W, Li X, Lü X, Li N, Gao X
and Song J: Preparation and in vitro antioxidant activity of
kappa-carrageenan oligosaccharides and their oversulfated,
acetylated, and phosphorylated derivatives. Carbohydr Res.
340:685–692. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Klarzynski O, Descamps V, Plesse B, Yvin
JC, Kloareg B and Fritig B: Sulfated fucan oligosaccharides elicit
defense responses in tobacco and local and systemic resistance
against tobacco mosaic virus. Mol Plant Microbe Interact.
16:115–122. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Guven KC, Ozsoy Y and Ulutin ON:
Anticoagulant, fibrinolytic and antiaggregant activity of
carrageenans and alginic acid. Botanica Marina. 34:429–432.
1991.
|
|
13
|
McGeer PL: Immune mechanisms in
neurodegeneration. Drugs Today. 32:149–158. 1996.
|
|
14
|
Xu L, Yao Z, Wu H, Wang F and Zhang S: The
immune regulation of κ-carrangeenan oligosaccharide and its
desulfated derivatives on LPS-activated microgial cells.
Neurochemistry International. 61:689–696. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ip YT and Davis RJ: Signal transduction by
the c-Jun N-terminal kinase (JNK)-from inflammation to development.
Curr Opin Cell Biol. 10:205–219. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shoji M, Iwakami N, Takeuchi S, Waragai M,
Suzuki M, Kanazawa I, Lippa CF, Ono S and Okazawa H: JNK activation
is associated with intracellular beta-amyloid accumulation. Brain
Res Mol Brain Res. 85:221–233. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhu X, Rottkamp CA, Kubat Z, et al:
Amyloid-beta toxicity is metal-mediated and acts through the
activation of JNk/SAPK pathway in Alzheimer disease. Society for
Neuroscience Abstracts. 27:8552001.
|
|
18
|
Fang F and Liu GT: Novel squamosamide
derivative (compound FLZ) attenuates Abeta25-35-induced toxicity in
SH-SY5Y cells. Acta Pharmacol Sin. 29:152–160. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Raynaud F and Marcilhac A: Implication of
calpain in neuronal apoptosis. A possible regulation of Alzheimer's
disease. FEBS J. 273:3437–3443. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Boatright KM and Salvesen GS: Mechanisms
of caspase activation. Curr Opin Cell Biol. 15:725–731. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen YR, Wang X, Templeton D, Davis RJ and
Tan TH: The role of c-Jun N-terminal kinase (JNK) in apoptosis
induced by ultraviolet C and gamma radiation. Duration of JNK
activation may determine cell death and proliferation. J Biol Chem.
271:31929–31936. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kumagae Y, Zhang Y, Kim OJ and Miller CA:
Human c-Jun N-terminal kinase expression and activation in the
nervous system. Brain Res Mol Brain Res. 67:10–17. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ghasemi R, Zarifkar A, Rastegar K,
Maghsoudi N and Moosavi M: Repeated intra-hippocampal injection of
beta-amyloid 25–35 induces a reproducible impairment of learning
and memory: Considering caspase-3 and MAPKs activity. Eur J
Pharmacol. 726:33–40. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Qin Y, Chen Z, Han X, Wu H, Yu Y, Wu J,
Liu S and Hou Y: Progesterone attenuates Aβ(25–35)-induced neuronal
toxicity via JNK inactivation and progesterone receptor membrane
component 1-dependent inhibition of mitochondrial apoptotic
pathway. J Steroid Biochem Mol Biol. 154:302–311. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yenki P, Khodagholi F and Shaerzadeh F:
Inhibition of phosphorylation of JNK suppresses Aβ-induced ER
stress and upregulates prosurvival mitochondrial proteins in rat
hippocampus. J Mol Neurosci. 49:262–269. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Troy CM, Rabacchi SA, Xu Z, Maroney AC,
Connors TJ, Shelanski ML and Greene LA: Beta-Amyloid-induced
neuronal apoptosis requires c-Jun N-terminal kinase activation. J
Neurochem. 77:157–164. 2001. View Article : Google Scholar : PubMed/NCBI
|
